Abstract
This study describes and analyzes Acinetobacter baumannii antibiotic susceptibly profile in Aleppo, Syria, thus providing vital information for guiding treatment of A baumannii infections. Two hundred sixty nonrepetitive A baumannii isolates were studied over 3.5 years. Resistance rates are at the higher end of globally reported levels. Newer cephalosporins and β-lactamase-resistant agents are becoming practically ineffective. Better activity is limited to carbapenems and colistin, which elicited the highest susceptibility levels.
Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.
MeSH terms
-
Acinetobacter Infections / drug therapy
-
Acinetobacter Infections / epidemiology
-
Acinetobacter Infections / microbiology*
-
Acinetobacter baumannii / drug effects*
-
Acinetobacter baumannii / isolation & purification
-
Adolescent
-
Adult
-
Anti-Bacterial Agents / pharmacology*
-
Anti-Bacterial Agents / therapeutic use
-
Carbapenems / pharmacology
-
Carbapenems / therapeutic use
-
Child
-
Child, Preschool
-
Colistin / pharmacology
-
Colistin / therapeutic use
-
Drug Resistance, Multiple, Bacterial
-
Humans
-
Infant
-
Microbial Sensitivity Tests
-
Prevalence
-
Respiratory Tract Infections / drug therapy
-
Respiratory Tract Infections / epidemiology
-
Respiratory Tract Infections / microbiology*
-
Retrospective Studies
-
Syria / epidemiology
-
Urinary Tract Infections / drug therapy
-
Urinary Tract Infections / epidemiology
-
Urinary Tract Infections / microbiology*
-
Young Adult
Substances
-
Anti-Bacterial Agents
-
Carbapenems
-
Colistin